Home

helps physicians and healthcare professionals

Erectile Dysfunction

helps physicians and healthcare professionals

Doctor123.org

helps physicians and healthcare professionals

Nephritic Syndrome, Emergency Medicine


Basics


Description


  • Acute glomerulonephritis (AGN) is acute inflammatory damage to glomerulus, associated with:
    • Abrupt onset of hematuria with or without RBC casts
    • Acute renal failure manifested by edema, hypertension, azotemia, decline in urine output
    • Variable proteinuria
    • Active urine sediment (RBC casts)
  • Exact mechanism of AGN unclear:
    • Combination of autoimmune reactivity to specific antigens at renal glomeruli
    • Characterized by crescent formation secondary to nonspecific injury at the glomerular wall

Etiology


  • Poststreptococcal glomerulonephritis (PSGN):
    • A postinfectious cause of acute nephritic syndrome, resulting from group A Ž ²-hemolytic streptococci
    • Considered a nonsuppurative complication (antibiotic treatment does not prevent this complication)
    • Occurs when immune complexes create hump-shaped subepithelial deposits in renal glomeruli
    • Most commonly affects patients between ages 3 and 15 yr but can occur at any age
    • Incidence of nephritis is 5 " “10% after pharyngitis and 25% after skin infections.
    • Consider PSGN in the setting of new-onset proteinuria, RBC casts, edema, and any recent infection.
    • Latent period between infection and onset of nephritis helps differentiate between PSGN and IgA nephropathy:
      • 1 " “3 wk in pharyngeal infection
      • 2 " “4 wk in cutaneous infection
    • Renal biopsy is usually not necessary for diagnosis.
    • Low complement (C3) for 6 " “8 wk
    • Can progress to severe renal failure if underlying infection goes untreated
    • Prognosis:
      • Excellent; >95% recover spontaneously with normalization of renal function within 6 " “8 wk, even with dialysis.
      • Hematuria usually resolves in 3 " “6 mo.
      • Transient nephrotic phase in 20% of patients during resolution of illness
      • End-stage renal disease occurs <5%
      • Rapidly progressive glomerulonephritis (RPGN) is rare, occurring in <1% cases.
      • Most cases resolve spontaneously with no long-term sequelae.
  • Other infectious sources of glomerulonephritis (GN):
    • Sepsis, pneumonia, endocarditis, viruses, HIV
    • Pulmonary, intra-abdominal, or cutaneous infections
    • Syphilis, leprosy, schistosomiasis, and malaria
    • Goal: Treat underlying infection.
  • Hepatitis virus " “related glomerular disease:
    • Can present with either nephritic or nephrotic symptoms
    • Causes membranoproliferative GN
    • Complements remain low indefinitely (compared to PSGN)
  • Noninfectious causes of GN (due to immune complex formation):
    • Systematic lupus erythematosus, Henoch " “Sch ƒ Άnlein purpura, vasculitis, Wegener granulomatosis
    • Goodpasture syndrome
  • IgA nephropathy (IgA-N)
    • Most common cause of AGN (>25%) worldwide
    • Antibody " “antigen causes immune complex deposition of IgA and C3
    • Complement levels are usually normal.
    • IgA-N has different presentations:
      • Gross hematuria following upper respiratory infection (URI)
      • Microscopic hematuria with proteinuria
      • Hematuria during viral illness or after exercise
      • Prognosis is related to serum creatinine, BP, and proteinuria.
      • 50% of patients with proteinuria may develop progressive renal disease.
      • ACE inhibitors or angiotensin-receptor blockers (ARBs) may help
  • RPGN:
    • Certain patients with AGN may progress rapidly to renal failure.
    • Hallmarks are crescents on renal biopsy.
  • Hereditary nephritis
    • Alport syndrome

Diagnosis


Signs and Symptoms


  • Hematuria:
    • Abrupt onset gross hematuria in 30 " “40% (coffee- or cola-colored urine)
  • Edema:
    • Periorbital edema
    • Generalized edema more common in infants and children
  • Infectious source or recent infection: Upper respiratory tract or skin common, e.g., PSGN
  • Symptoms of congestive heart failure:
    • 40% occurrence in patients >60 yr
    • Rare in children
  • Arthritis, arthralgias, and various skin rashes: PSGN, systemic disease
  • Nonspecific manifestations:
    • Malaise
    • Weakness
    • Anorexia
    • Nausea/vomiting

History
  • Recent URI or skin or other infection
  • Change in urine color

Physical Exam
  • Hypertension
  • Edema

Essential Workup


Urinalysis with sediment evaluation to detect: ‚  
  • RBCs, proteinuria, and RBC casts
  • RBC casts are diagnostic of an active glomerular inflammation.

Diagnosis Tests & Interpretation


Lab
  • CBC:
    • Anemia (seen in more chronic cases of GN or other systemic disease)
    • Acute leukocytosis (may suggest infectious process)
  • Basic metabolic panel:
    • Assess baseline renal function
    • Check for electrolyte abnormalities
    • GFR will be normal or nearly normal
  • Urinalysis:
    • RBCs +/ ’ ˆ ’ casts, protein
  • Serum albumin
  • Cultures (throat, skin, urine, blood):
    • As clinically suspected for infectious source
    • Streptozyme
  • Serum complement level (C3): Decreased in infectious endocarditis, shunt nephritis, and PSGN
  • Streptococcal antibodies:
    • Antistreptolysin (ASO), antistreptokinase (ASK), antideoxyribonuclease B (ADNase B), antinicotinyl adenine dinucleotidase (ANADase), and antihyaluronidase (AH)
    • ASO more reactive in pharyngeal infections
    • ADNase B, ANADase, and AH more reactive in cutaneous infections
    • ASK elevated in recent hemolytic Streptococcus infections
    • Titers do not correlate with prognosis of disease
  • Urine osmolality, sodium, creatinine
  • 24-hr urine collection:
    • Proteinuria initially present in 5% of children, 20% of adults with PSGN

Imaging
  • Renal ultrasound: Kidney size abnormality
  • Chest radiograph: Cardiomegaly, pulmonary edema, infection

Diagnostic Procedures/Surgery
Renal biopsy: ‚  
  • Generally not done for PSGN, as symptoms typically resolve after a brief illness
  • Recommended if atypical features of PSGN, persistently abnormal complement levels, persistent hypertension, and proteinuria >3 g/d
  • Facilitates diagnosis for other causes of nephritis

Differential Diagnosis


  • (See "Glomerulonephritis "  for further information on types of GN)
  • Renal:
    • Primary glomerular disease
  • Systemic:
    • Goodpasture syndrome
    • Vasculitis
    • Henoch " “Sch ƒ Άnlein purpura
  • Other (rare):
    • Hemolytic-uremic syndrome
    • Thrombotic thrombocytopenic purpura
    • Acute hypersensitivity interstitial nephritis
    • Serum sickness

Treatment


Pre-Hospital


Support ABCs ‚  

Initial Stabilization/Therapy


ABCs ‚  

Ed Treatment/Procedures


  • Antibiotics for streptococcal infection:
    • Penicillin (erythromycin, if penicillin allergic)
  • Restrict salt and fluid intake
  • Administer loop diuretics (furosemide)
  • Restore urine flow in oliguric patients:
    • Mannitol
  • Treat pulmonary edema:
    • Oxygen
    • Morphine
    • Loop diuretics
  • Stabilize BP to decrease proteinuria, retard progression of GN:
    • ACEIs, ARBs
    • Hypertensive emergency: Nitroprusside or other titratable antihypertensive medication
  • Hemodialysis for:
    • Severe hyperkalemia
    • Fluid overload
    • Uremia
    • Severe acidosis
    • Correct electrolyte abnormalities

Medication


  • Erythromycin: 250 " “500 mg (peds: 30 " “50 mg/kg/d) PO q6h for 7 " “10 days
  • Furosemide: 20 " “80 mg (peds: 1 " “6 mg/kg) PO daily/BID
  • Lisinopril (ACEI): 10 " “40 mg (peds: >6 yr: 0.07 mg/kg) PO daily
  • Losartan (ARB): 25 " “100 mg (peds: >6 yr: 0.7 mg/kg) PO daily
  • Mannitol: 12.5 " “100 g (peds: 0.25 " “0.5 g/kg) IV:
    • May use single or repeat dosing; consider test dosing 1st.
  • Morphine sulfate: 0.1 mg/kg/dose IV q4h
  • Nitroprusside: 0.3 " “4 Ž Όg/kg/min IV
    • Titrate to goal mean arterial pressure for hypertensive emergency.
  • Penicillin:
    • Benzathine penicillin: 1.2 million U (peds: 0.3 " “0.9 million U, based on weight) IM as single dose
    • Penicillin VK: 250 " “500 mg (peds: <12 yr 25 " “50 mg/kg/d) PO q6 " “8h for 10 days
  • Other agents, including fish oil (  ‰-3 fatty acids for anti-inflammatory effects) and immunosuppressive agents (glucocorticoids, cyclophosphamide), may be used in consultation with specialists.

Follow-Up


Disposition


Admission Criteria
  • Evidence of infectious cause for GN
  • Oliguria, anuria
  • Uremia
  • Elevated creatinine
  • Edema
  • Electrolyte abnormalities
  • Severe hypertension
  • CHF

Discharge Criteria
Mild cases of clinical nephritis in healthy patients with: ‚  
  • No comorbid illness
  • Strict supervision/monitoring of symptoms, diet, urine output, and medication
  • Close follow-up with PMD and nephrology referral

Issues for Referral
Nephrology: ‚  
  • Within 2 " “3 days

Follow-Up Recommendations


  • Adherence to antibiotic and antihypertensive therapy, as indicated
  • Restrict salt and fluid intake.

Pearls and Pitfalls


  • Diagnosis is confirmed by biopsy showing characteristic crescent formation within renal glomeruli.
  • Must obtain thorough history of ongoing or recent infections as possible etiology of nephritis
  • IgA nephropathy is most common cause of nephritis.
  • Patients require aggressive management of BP and volume status.

Additional Reading


  • Ikee ‚  R, Kobayashi ‚  S, Saigusa ‚  T, et al. Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy. Hypertens Res.  2006;29(1):15 " “22.
  • Kanjanabuch ‚  T, Kittikowit ‚  W, Eiam-Ong ‚  S. An update on acute postinfectious glomerulonephritis worldwide. Nat Rev Nephrol.  2009;5:259 " “269.
  • Kunz ‚  R, Friedrich ‚  C, Wolbers ‚  M, et al. Meta-analysis: Effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease. Ann Intern Med.  2008;148(1):30 " “48.

See Also (Topic, Algorithm, Electronic Media Element)


  • Acute Renal Failure
  • Glomerulonephritis
  • Nephrotic Syndrome

Codes


ICD9


  • 580.0 Acute glomerulonephritis with lesion of proliferative glomerulonephritis
  • 580.9 Acute glomerulonephritis with unspecified pathological lesion in kidney
  • 583.2 Nephritis and nephropathy, not specified as acute or chronic, with lesion of membranoproliferative glomerulonephritis
  • 583.4 Nephritis and nephropathy, not specified as acute or chronic, with lesion of rapidly progressive glomerulonephritis

ICD10


  • N00.9 Acute nephritic syndrome with unsp morphologic changes
  • N01.9 Rapidly progr nephritic syndrome w unsp morphologic changes
  • N05.9 Unsp nephritic syndrome with unspecified morphologic changes
  • N05.1 Unsp neph syndrome w focal and segmental glomerular lesions
  • N05.0 Unsp nephritic syndrome with minor glomerular abnormality
  • N05.2 Unsp nephritic syndrome w diffuse membranous glomrlneph
  • N05.3 Unsp neph syndrome w diffuse mesangial prolif glomrlneph
  • N05.4 Unsp neph syndrome w diffuse endocaplry prolif glomrlneph
  • N05.5 Unsp nephritic syndrome w diffuse mesangiocap glomrlneph
  • N05.6 Unspecified nephritic syndrome with dense deposit disease
  • N05.7 Unsp nephritic syndrome w diffuse crescentic glomrlneph
  • N05.8 Unsp nephritic syndrome with other morphologic changes
  • N05 Unspecified nephritic syndrome

SNOMED


  • 7724006 Nephritic syndrome (disorder)
  • 19351000 Acute glomerulonephritis (disorder)
  • 236392004 Rapidly progressive glomerulonephritis (disorder)
  • 80321008 Mesangiocapillary glomerulonephritis (disorder)
  • 68544003 Acute post-streptococcal glomerulonephritis (disorder)
Copyright © 2016 - 2017
Doctor123.org | Disclaimer